Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 6 | Cellular & Molecular Biology Letters

Fig. 6

From: The crosstalk between alternative splicing and circular RNA in cancer: pathogenic insights and therapeutic implications

Fig. 6

Therapeutic application of circRNA and alternative splicing. The crosstalk between circRNA and alternative splicing (AS) carries great therapeutic potential. Detecting alterations in patient circRNA transcriptome and AS pattern provides valuable information for molecular therapy design and a patient profile that is indicative of therapeutic response and prognosis, which contributes to precision medicine in cancer treatment. Moreover, circRNAs are promising therapeutic targets. Engineered circRNAs are capable of modulating gene expression through multiple mechanisms to modulate gene expression in cancer cells, thereby serving as a potent anticancer agent

Back to article page

Cellular & Molecular Biology Letters

ISSN: 1689-1392

Contact us